ADAM10 and Alzheimer disease: Thus, RA-induced stimulation of ADAM10 expression is likely to be physiologically relevant for further anti-AD therapy through the increase in APPα secretion and/or decrease of Aβ production in vitro [14,15], as well as in AD patients treated with acitretin, a vitamin A derivative [16].